image
Sarepta Therapeutics, Inc. SRPT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 46.75
-26.6 %
$ 4.59 B
Market Cap
19.98
P/E
INCOME STATEMENT
1.9 B REVENUE
52.97%
Growth Rates
1Year 52.97%
3Years 39.42%
5Years 37.94%
7Years 43.13%
10Years 69.43%
218 M OPERATING INCOME
181.43%
Growth Rates
1Year 181.43%
3Years 35.45%
5Years 19.31%
7Years 18.45%
10Years 13.76%
235 M NET INCOME
143.89%
Growth Rates
1Year 143.89%
3Years 36.83%
5Years 18.42%
7Years 31.06%
10Years 14.08%
EFFICIENCY
Earnings Waterfall Sarepta Therapeutics, Inc.
image
Revenue 1.9 B
Cost Of Revenue 319 M
Gross Profit 1.58 B
Operating Expenses 1.36 B
Operating Income 218 M
Other Expenses -17.2 M
Net Income 235 M
2b2b2b2b2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m002b(319m)2b(1b)218m17m235mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995
REVENUE
Revenue 1 902.0 1 243.3 933.0 701.9 540.1 380.8 301.0 154.6 5.4 1.3 9.8 14.2 37.3 47.0 29.4 17.6 21.3 11.0 0.1 4.8 0.4 1.0 0.8 0.7 1.3 100 K 0.2 100 K 100 K 100 K
GROSS PROFIT
Cost Of Revenue 319.1 150.3 140.0 97.0 63.4 56.6 34.2 7.4 0.1 146.2 94.1 90.3 51.9 35.9 27.5 0 0 0 0 0 0 0 0 0 (0.4) 0 (0.2) (0.5) (0.5) 0
Gross Profit 1 582.9 1 093.0 793.0 604.8 476.7 324.2 266.8 147.2 5.3 (144.9) (84.3) (76.1) (14.6) 11.1 2.0 17.6 21.3 11.0 0.1 4.8 0.4 1.0 0.8 0.7 1.7 100 K 0.4 0.6 0.6 100 K
OPERATING INCOME
Operating Expenses 1 364.8 1 360.8 1 329.2 1 054.5 1 040.9 846.6 610.5 290.4 272.0 221.4 143.5 104.5 67.0 82.9 50.4 33.1 38.8 44.1 33.1 22.3 25.5 19.8 26.2 16.1 12.0 8.4 8.1 4.5 2.8 2.7
Selling, General and Administrative Expenses 557.9 481.9 451.4 282.7 317.9 284.8 207.8 122.7 83.7 75.0 49.3 31.6 14.6 16.1 14.4 8.7 9.8 9.3 7.8 5.2 4.7 4.6 3.8 3.4 2.3 1.7 1.6 1.3 0.6 0.6
Research and Development Expenses 804.5 877.4 877.1 771.2 722.3 560.9 401.8 166.7 188.3 146.4 94.2 72.9 52.4 66.9 36.0 24.4 29.0 34.8 25.3 17.1 20.7 15.3 22.4 12.8 9.3 6.7 6.3 2.7 1.7 2.1
Operating Income 218.1 (267.8) (536.2) (449.7) (564.2) (522.3) (343.6) (171.6) (266.7) (220.2) (133.8) (90.3) (29.7) (35.9) (20.9) (15.5) (27.5) (33.1) (33.0) (17.5) (25.0) (18.9) (25.3) (15.4) (10.2) (8.3) (7.7) (3.9) (2.2) (2.6)
PRE-TAX INCOME
Interest Income Expense 18.4 22.0 53.2 63.5 59.9 30.7 33.7 5.8 1.9 0 0 0.3 0 90 K 0.3 0.5 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Other Income 42.7 (252.3) (153.8) 40.8 11.1 (8.3) (19.0) 123.0 (0.5) 0.2 (2.0) (21.7) (92.2) 33.6 (11.2) (9.2) (6.4) 5.9 1.9 0.8 0.3 4.3 (4.0) 7.1 1.0 100 K (19.0) 0.4 0.2 0
Pre-Tax Income 260.8 (520.1) (690.0) (418.9) (553.1) (713.9) (362.6) (48.6) (267.3) (220.0) (135.8) (112.0) (121.3) (2.3) (24.0) (24.7) (24.0) (28.2) (31.1) (16.7) (24.8) (14.6) (29.4) (8.3) (9.2) (8.4) (26.7) (3.5) (2.0) (2.6)
NET INCOME
Tax Provision 25.5 15.9 13.5 (0.2) 1.1 1.2 (0.7) 2.1 (7.6) (5.2) (1.7) 20.4 91.6 (34.9) 11.2 9.7 6.4 (5.9) 0 0 0 (4.3) 4.0 11.5 0 0 19.0 (0.3) 100 K 0
Net Income 235.2 (536.0) (703.5) (418.8) (554.1) (715.1) (361.9) (50.7) (267.3) (220.0) (135.8) (112.0) (121.3) (2.3) (32.2) (25.2) (24.0) (27.2) (31.1) (16.7) (24.8) (14.6) (29.4) (26.9) (9.2) (8.3) (26.7) (3.6) (2.1) (2.6)
EPS 2.47 5.8 8.03 5.15 7.11 9.71 5.46 0.86 5.49 5.2 3.39 3.31 5.14 0.11 1.74 1.62 2.07 3.02 3.54 2.24 4.13 2.94 6.86 7.21 2.96 3.71 13.6 2.14 1.5 2.17